Q&A With Paul Hudson of AstraZeneca US: Proving Value in Diabetes Care

As the healthcare landscape has changed in recent years everyone from patients to doctors to pharmaceutical companies have had to change along with it.Paul Hudson, President of AstraZeneca US discussed how the changes have affected the industry during the American Diabetes Association's 75th Annual Scientific Sessions in Boston. Hudson said pharmaceutical companies now need to work closer with providers to ensure they are getting the best product possible to help their patients "for the most sensible use of the healthcare dollar in the United States."